Last update 13 Jan 2026

TER-2013

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
TER-2013
Target
Akt-1
Action
inhibitors
Mechanism
Akt-1 inhibitors(Serine/threonine-protein kinase AKT1 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [4]
Active Indication
Breast CancerEndometrial CarcinomaEsophageal Squamous Cell Carcinoma+ [4]
Inactive Indication-
Originator Organization
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
Active Organization
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with TER-2013
NCT07109726
/ RecruitingPhase 1/2
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
100 Clinical Results associated with TER-2013
Login to view more data
100 Translational Medicine associated with TER-2013
Login to view more data
100 Patents (Medical) associated with TER-2013
Login to view more data
100 Deals associated with TER-2013
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
Endometrial CarcinomaPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
Esophageal Squamous Cell CarcinomaPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
Ovarian CancerPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
Squamous Cell Carcinoma of Head and NeckPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
squamous cell lung carcinomaPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
Uterine Cervical CancerPhase 2
United States
Terremoto Biosciences, Inc.Terremoto Biosciences, Inc.
23 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free